Cambridge Heart Announces Unique
Reimbursement Code and Medicare Payment Amount for Microvolt T-Wave Alternans
Bedford MA – January 1st, 2003 -- Cambridge Heart, Inc. (NASDAQ-CAMH) announced today
that a Current Procedural Terminology (CPT) code with a specific Medicare
payment amount for its Microvolt T-Wave Alternans testing has been published
in the Federal Register. Effective January 1, 2003, CPT code 93025 may be
billed electronically. The national Medicare payment amount for the test will
is unique to Microvolt T-Wave Alternans and may be used alone or in
conjunction with other diagnostic cardiovascular tests when submitting for
reimbursement of claims to either Medicare or private insurers. For the first
time, providers will be able to file for reimbursement of a Microvolt T-Wave
Alternans Test electronically and be confident of the amount of payment.
are pleased to see a reimbursement amount for Microvolt T-Wave Alternans that
reflects its importance as a key tool in the diagnostic armamentarium of the
cardiologist," stated David A. Chazanovitz, President and CEO of
Cambridge Heart, Inc. "Our customers can now perform an alternans test
on appropriate patients knowing that the reimbursement filing process has
been simplified and that a reasonable payment is available."
Chazanovitz also stated, "This removes a significant barrier to our
efforts to increase market penetration and establish broad clinical use of
our technology and ultimately establish Microvolt T-Wave Alternans as a
standard of care for patients at risk of sudden cardiac death."